China NT Pharma Group Company Limited (1011.HK)

HKD 0.41

(-7.87%)

Total Assets Summary of China NT Pharma Group Company Limited

China NT Pharma Group Company Limited's latest annual total assets in 2023 was 329.12 Million CNY , down -67.27% from previous year.
China NT Pharma Group Company Limited's latest quarterly total assets in 2024 Q2 was 338.76 Million CNY , down 0.0% from previous quarter.
China NT Pharma Group Company Limited reported annual total assets of 1 Billion CNY in 2022, up 5.27% from previous year.
China NT Pharma Group Company Limited reported annual total assets of 955.36 Million CNY in 2021, down -26.23% from previous year.
China NT Pharma Group Company Limited reported quarterly total assets of 1.05 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
China NT Pharma Group Company Limited reported quarterly total assets of 329.12 Million CNY for 2023 FY, down -67.27% from previous quarter.

Annual Total Assets Chart of China NT Pharma Group Company Limited (2023 - 2010)

Historical Annual Total Assets of China NT Pharma Group Company Limited (2023 - 2010)

Year	Total Assets	Total Assets Growth
2023	329.12 Million CNY	-67.27%
2022	1 Billion CNY	5.27%
2021	955.36 Million CNY	-26.23%
2020	1.29 Billion CNY	-27.98%
2019	1.79 Billion CNY	-19.26%
2018	2.22 Billion CNY	-19.3%
2017	2.75 Billion CNY	7.69%
2016	2.56 Billion CNY	83.27%
2015	1.39 Billion CNY	-5.86%
2014	1.48 Billion CNY	3.04%
2013	1.44 Billion CNY	-35.21%
2012	2.22 Billion CNY	-37.69%
2011	3.57 Billion CNY	29.6%
2010	2.75 Billion CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	338.76 Million CNY	0.0%
2023 Q2	1.05 Billion CNY	0.0%
2023 FY	329.12 Million CNY	-67.27%
2023 Q4	329.12 Million CNY	0.0%
2022 Q2	963.11 Million CNY	0.0%
2022 FY	1 Billion CNY	5.27%
2022 Q4	1 Billion CNY	0.0%
2021 Q2	1.12 Billion CNY	0.0%
2021 Q4	955.36 Million CNY	0.0%
2021 FY	955.36 Million CNY	-26.23%
2020 FY	1.29 Billion CNY	-27.98%
2020 Q2	1.76 Billion CNY	0.0%
2020 Q4	1.29 Billion CNY	0.0%
2019 Q2	2.34 Billion CNY	0.0%
2019 FY	1.79 Billion CNY	-19.26%
2019 Q4	1.79 Billion CNY	0.0%
2018 Q2	2.76 Billion CNY	0.0%
2018 FY	2.22 Billion CNY	-19.3%
2018 Q4	2.22 Billion CNY	0.0%
2017 FY	2.75 Billion CNY	7.69%
2017 Q2	2.92 Billion CNY	0.0%
2017 Q4	2.75 Billion CNY	0.0%
2016 FY	2.56 Billion CNY	83.27%
2016 Q4	2.56 Billion CNY	0.0%
2016 Q2	1.44 Billion CNY	0.0%
2015 Q4	1.39 Billion CNY	0.0%
2015 FY	1.39 Billion CNY	-5.86%
2015 Q2	1.09 Billion CNY	0.0%
2014 Q4	1.48 Billion CNY	0.0%
2014 Q2	1.47 Billion CNY	0.0%
2014 FY	1.48 Billion CNY	3.04%
2013 Q4	1.44 Billion CNY	0.0%
2013 FY	1.44 Billion CNY	-35.21%
2013 Q2	1.75 Billion CNY	0.0%
2012 Q2	3.5 Billion CNY	0.0%
2012 Q4	2.22 Billion CNY	0.0%
2012 FY	2.22 Billion CNY	-37.69%
2011 Q4	3.57 Billion CNY	0.0%
2011 Q2	3.53 Billion CNY	0.0%
2011 FY	3.57 Billion CNY	29.6%
2010 Q4	2.75 Billion CNY	0.0%
2010 FY	2.75 Billion CNY	0.0%

Peer Total Assets Comparison of China NT Pharma Group Company Limited

Name	Total Assets	Total Assets Difference
Pak Fah Yeow International Limited	907.46 Million HKD	63.732%
Grand Pharmaceutical Group Limited	22.51 Billion HKD	98.538%
Extrawell Pharmaceutical Holdings Limited	1.28 Billion HKD	74.431%
Wai Yuen Tong Medicine Holdings Limited	2.09 Billion HKD	84.291%
Qianhai Health Holdings Limited	478.11 Million HKD	31.163%
Lee's Pharmaceutical Holdings Limited	2.89 Billion HKD	88.614%
Essex Bio-Technology Limited	2.82 Billion HKD	88.36%
Tongfang Kontafarma Holdings Limited	1.72 Billion HKD	80.946%
PuraPharm Corporation Limited	843.96 Million HKD	61.003%
SSY Group Limited	11.96 Billion HKD	97.25%
JBM (Healthcare) Limited	1.38 Billion HKD	76.3%
Jacobson Pharma Corporation Limited	3.48 Billion HKD	90.561%
China Resources Pharmaceutical Group Limited	271.69 Billion HKD	99.879%